PROVIDER PROFILE · NPI 1396190567

Anna BetlachinMD

MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
542
Unique beneficiaries
—
Total services
28,017
Distinct HCPCS
10
Medicare payment
$322K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — top quintile (cohort median 1,164).
PRESCRIBING · PART D · 2024
Total Rx claims
2,133
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
33
Brand share
54.2%
Top prescribed drugs
Tirzepatide360 claims
Semaglutide114 claims
Metformin Hcl110 claims
Metformin Hcl98 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
83.7
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

Hospital
Hospital